Press Releases

Programs reauthorized and funded in the Senate Agriculture Committee's version of the Farm Bill are valuable to the biotechnology industry.

The Biotechnology Industry Organization (BIO) today submitted a statement for the record to the House Ways and Means Subcommittee on Select Revenue Measures for a hearing on “Certain Expiring Tax Provisions”. 

BIO President and CEO Jim Greenwood released the following statement regarding the Obama Administration's new National Bioeconomy Blueprint issued today.

BIO today thanked Sens. Richard Lugar (R-Ind.), Kent Conrad (D-N.D.), and nine others for offering an amendment to improve the 2012 Farm Bill by providing mandatory funding for energy title programs that are helping revitalize rural America and build new agricultural markets

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Michael Enzi (R-WY) as a Legislator of the Year for 2011-2012.

The Biotechnology Industry Organization (BIO) announced today its selection of Representative Allyson Schwartz (D-PA) as Legislator of the Year for 2011-2012.

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Kay Hagan (D-NC) as Legislator of the Year for 2011-2012.

The Biotechnology Industry Organization (BIO) announced today its selection of Representative Mike Rogers (R-MI) as Legislator of the Year for 2011-2012.

The Biotechnology Industry Organization (BIO) announced today its selection of Senator Robert Menendez (D-NJ) as Legislator of the Year for 2011-2012.

The Biotechnology Industry Organization (BIO) announced today its selection of Representative Jack Kingston (R-GA) as Legislator of the Year for 2011-2012.

Representatives from the Dow Chemical Company, Coca Cola, the National Defense Center for Energy and Environment and more will discuss the innovative use of industrial biotech in consumer products. 

This global event for biotechnology will be held June 18-21, 2012 in Boston.

Nominations for the award close on April 20.

The Biotechnology Industry Organization (BIO) submitted comments yesterday to the U.S. Food and Drug Administration (FDA) on three draft guidance documents on biosimilar products.

(BIO) announced the industrial biotechnology companies selected to present their technology development and business models to investors and analysts at BIO’s 9th annual World Congress on Industrial Biotechnology and Bioprocessing.

The Biotechnology Industry Organization expressed strong support for the signing of the Jumpstart Our Business Startups (JOBS) Act into law today.

BIO joined 100 renewable energy, energy efficiency, farm, ranch, commodity, environmental, and other groups in a letter to the leaders of the House and Senate Agriculture Committees asking for reauthorization and funding of Farm Bill energy title programs.

Executives from brand-name consumer product companies will discuss the strategies for adoption of industrial biotech innovations in plenary and breakout sessions at BIO’s 9th annual World Congress on Industrial Biotechnology and Bioprocessing.

Centric Health Resources and the National Organization for Rare Disorders (NORD), Co-organizersAlnylam Pharmaceuticals, Genzyme, a Sanofi Company and Millennium: The Takeda Oncology Company, Co-sponsors

Domestic biofuel production is necessary for energy and national security, the Biotechnology Industry Organization (BIO) emphasized today in a letter to the leaders of the House Armed Services Committee and its Subcommittee on Readiness. 

Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization (BIO), testified today on biosimilar user fees (BsUFA) and the Prescription Drug User Fee Act (PDUFA) before the Senate Health, Education, Labor and Pensions Committee.

BIO has named Steen Riisgaard as the recipient of its 2012 George Washington Carver Award for innovation in industrial biotechnology.